MUMBAI, India, Aug. 31 -- Intellectual Property India has published a patent application (202617081434 A) filed by Hubei Bio-Pharmaceutical on July 01, 2026, for Mrgprx2 Antagonist And Use Thereof.
Inventors include Zhang, Xuejun; Zang, Yang; Yang, Hui Wo No; Zhu, Haiyong; Li, Xiaopei Application Number; Li, Jinping; Liu, Lifei; Qian, Lina Number; Zhu, Shengji; and Li, Yuqiong.
The application for the patent was published on August 28, 2026, under issue no. 35/2026.
Abstract: Provided in the present invention are a compound as shown in formula IA, a tautomer, stereoisomer, hydrate, solvate, pharmaceutically acceptable salt or prodrug thereof. The compound has a good MRGPRX2 antagonistic effect.
Disclaimer: Curated by HT Syndication.
